ArticleCancers2025

Real-World Outcomes and Biomarker Analysis Based on Routine Clinical, Laboratory, and Pathologic Parameters in Metastatic or Unresectable Esophageal Cancer Treated with First-Line Anti-PD-1 Plus Fluoropyrimidine and Platinum.

Jiyun Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.